GlassScriptPhysician profile
Edward Rampersaud
NPI 1205003092
$4,909.04
in general payments reported to CMS, 2019-2025
30 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $91.91 · 2021: $279 · 2023: $3,149 · 2024: $353 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,550 · Education: $1,565 · Travel and Lodging: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,550.40 |
| Education | $1,565.00 |
| Travel and Lodging | $422.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,949.78 | 2023 | Davinci Xi, Da Vinci Surgical System |
| Astellas Pharma US INC | $433.10 | 2021-2025 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $404.04 | 2021-2025 | Erleada |
| Sumitomo Pharma America, INC. | $348.02 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $269.30 | 2023-2025 | Rezum Generator, Spaceoar Vue System - 10ml, General - Erectile Dysfunction |
| Teleflex LLC | $156.66 | 2023 | Urolift |
| Pfizer INC. | $155.92 | 2021-2025 | |
| Axonics, INC. | $124.37 | 2021 | |
| Abbvie INC. | $110.11 | 2023-2025 | |
| Endo USA, INC. | $98.24 | 2024-2025 | Xiaflex |
| Olympus America INC. | $94.26 | 2021-2025 | Itind System |
| Baxter Healthcare | $91.91 | 2020 | |
| Urogen Pharma, INC. | $87.16 | 2023-2024 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $81.34 | 2021-2024 | Provenge |
| Medtronic, INC. | $69.37 | 2025 | Interstim |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $56.05 | 2023 | Prolaris |
| Novartis Pharmaceuticals Corporation | $45.46 | 2025 | |
| Merck Sharp & Dohme LLC | $44.50 | 2023 | Keytruda, Lynparza |
| Ferring Pharmaceuticals INC. | $38.51 | 2024-2025 | Adstiladrin |
| Steris Corporation | $26.83 | 2025 | |
| Ethicon US, LLC | $26.60 | 2025 | Dermabond Prineo, Stratafix, Surgicel Nu-Knit |
| Blue Earth Diagnostics | $26.55 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.74 | 2024 | |
| Procept Biorobotics Corporation | $24.65 | 2024 | Aquabeam System |
| Profound Medical Corp. | $23.83 | 2025 | Tulsa-Pro |
| Bard Peripheral Vascular, INC. | $23.42 | 2025 | Model 200 Theraseed Palladium-103 In Readylink |
| Antares Pharma, INC. | $22.55 | 2023 | Tlando, Xyosted, Nocdurna |
| Progenics Pharmaceuticals, INC. | $20.43 | 2025 | |
| Halozyme INC | $16.54 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.80 | 2023 | Imfinzi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Rampersaud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.